U.S. Agencies Seize Over $7 Million in Illegal E-Cigarettes as FDA Pledges Continued Crackdown

Jan.11.2025
U.S. Agencies Seize Over $7 Million in Illegal E-Cigarettes as FDA Pledges Continued Crackdown
The Miami operation, announced on January 10, is the latest joint effort by multiple U.S. federal agencies to combat illegal e-cigarettes, resulting in the seizure of over $7 million worth of unauthorized products. The FDA emphasized that an “All Government” approach is critical in addressing the issue of illegal e-cigarettes.

Key Points:

 

1. This is another significant enforcement action following the October 2024 seizure of $76 million worth of illegal e-cigarettes.

 

2. Recently, the FDA has issued a series of announcements, including the January 3 announcement regarding updates to import alerts, allowing all unauthorized e-cigarettes to be detained without physical examination. These actions signal an acceleration of the FDA’s crackdown on illegal e-cigarettes.

 

3. In this announcement, Geek Bar was once again the only brand explicitly named, with the FDA stating that it “may appeal to youth.” This underscores the FDA’s close attention to the brand.

 

4. The details disclosed in this announcement—such as the seizure in Miami and the methods by which illegal products entered the U.S.—demonstrate the increasing precision and efficiency of enforcement under multi-agency cooperation.

 

5. The head of the FDA’s Center for Tobacco Products emphasized the importance of the “All Government” approach, in combating illegal e-cigarettes. This suggests that additional cases of illegal e-cigarette seizures may occur in the future.

 

 

 

[January 10, 2025] U.S. federal agencies announced the seizure of more than 628,000 unauthorized e-cigarette products from a warehouse in Miami, with a retail value exceeding $7 million. The confiscated items included flavored disposable e-cigarettes, kits, and batteries, with some products from brands like Geek Bar, which are known to appeal to youth.

 

The operation, led by U.S. Customs and Border Protection (CBP), uncovered shipments of illegal e-cigarette products originating from China and destined for various U.S. states. Investigations revealed that these products were intentionally misdeclared and undervalued—common tactics to evade detection and duties. Following referrals to the FDA’s Center for Tobacco Products, authorities confirmed the products lacked mandatory premarket authorization, rendering them illegal for sale or distribution in the U.S.

 

“An ‘All Government’ approach is critical to preventing unauthorized e-cigarettes from entering the United States” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products. “Today’s action is another step in the right direction, and we remain committed to continuing to work with our federal partners to continue to combat the entry of these illegal products head on.”

 

Confiscated products, like those seized in this operation, are typically disposed of in compliance with federal regulations. For unauthorized tobacco products, including e-cigarettes, this generally means destruction.

 

The Miami operation is part of an intensified federal crackdown on illegal e-cigarette distribution. It follows a $76 million seizure of unauthorized e-cigarettes in October 2024 and builds on efforts spearheaded by a federal task force established in June 2024 to streamline enforcement. These coordinated actions aim to hold violators accountable by leveraging criminal and civil tools across multiple agencies.

 

To date, the FDA has authorized only 34 e-cigarette products and devices for legal sale in the U.S. More information on authorized tobacco products can be found in the FDA’s Searchable Tobacco Products Database.

 

Original FDA Announcement : Over $7 Million Worth of Illegal E-Cigarettes Seized in Federal Operation

 

 

 

2Firsts Editorial Note:

 

Since the second half of 2024, U.S. agencies have continued their crackdown on illegal e-cigarettes. Through coordinated efforts across multiple federal departments, these enforcement actions have achieved increasingly significant results, reflecting the U.S. federal government’s determination and strategic optimization in combating illegal e-cigarettes.

 

2Firsts has been closely monitoring U.S. regulatory actions on e-cigarettes. At the recently concluded 2Firsts 2024 Global NGP Compliance Development Symposium, 2Firsts invited several U.S. compliance experts to provide detailed insights into U.S. compliance policies for e-cigarette companies. Additionally, in 2Firsts’ 2024 Global Top 10 NGP News, the story titled “1. U.S. E-Cigarette Regulations Intensify, Setting the Stage for a Major Market Shakeup” ranked first.

 

 

 

Recent 2Firsts reports on U.S. regulations include:

 

1.FDA Strengthens Import Alerts to Address Unauthorized E-Cigarettes Detention

 

2.FDA Warns 9 Online Firms for Illegally Selling Flavored, Disposable E-Cigarettes, Including Geek Bar and Lost Mary

 

3.FDA Outlines Recent Regulatory Actions to 2Firsts: Comprehensive Oversight and Strategies Adapting to Market Changes


4.U.S. FDA's 2024 Illicit E-Cigarette Crackdown: Full-Spectrum Enforcement and Targeted Actions Against Geekvape and Heaven Gifts

 

5.FDA, CBP seize 3 million illegal e-cigarette products worth $76 million, including GEEKBAR

 

6.U.S. Regulatory Storm to Drive Profound Changes in China's E-Cigarette Supply Chain, Says Alan Zhao, CEO of 2Firsts

 


 

2Firsts welcomes article submissions, interview opportunities, or commentary. Please contact us at info@2firsts.com or connect with 2Firsts CEO Alan Zhao on LinkedIn here.

 

On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.
Regulations
Nov.11
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09